Academic staff at First Faculty of Medicine, Faculty of Medicine in Pilsen, Third Faculty of Medicine, Central Library of Charles University, Faculty of Medicine in Hradec Králové, Second Faculty of Medicine
Publications
- The New England Journal of Medicine Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia2025 | Faculty of Medicine in Hradec Králové
- Léčebné postupy v hematologii Autologní a alogenní transplantace krvetvorných buněk a přehled jejich indikací v České republice v roce 20242024 | Second Faculty of Medicine, Faculty of Medicine in Hradec Králové, Central Library of Charles University
- Lymphocyte profile in peripheral blood of patients with multiple myeloma2024 | Faculty of Medicine in Pilsen
- Journal of Clinical Investigation FoxO1/Rictor axis induces a nongenetic adaptation to ibrutinib via Akt activation in chronic lymphocytic leukemia2024 | Faculty of Medicine in Hradec Králové
- PLoS One Enhancing reproducibility in single cell research with biocytometry: An inter-laboratory study2024 | Publication without faculty affiliation
- Type I interferon signaling in malignant blasts contributes to treatment efficacy in AML patients2023 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Pilsen
- Idelalisib plus rituximab versus ibrutinib in the treatment of relapsed/refractory chronic lymphocytic leukaemia: A real-world analysis from the Chronic Lymphocytic Leukemia Patients Registry (CLLEAR)2023 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- COVID-19 in patients with chronic lymphocytic leukemia: a multicenter analysis by the Czech CLL study group2023 | Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové, Central Library of Charles University
- Managing BTK inhibitor treatment-related adverse events in patients with chronic lymphocytic leukaemia - cardiovascular complications and bleeding2023 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Determinants of refined GvHD-free, relapse-free survival after reduced-intensity allogeneic hematopoietic cell transplantation in older patients with myeloid malignancies2023 | Faculty of Medicine in Pilsen
Loading network view...
